The records of 194 patients with thyroid carcinoma treated with131I, representing all cases thus treated in Denmark from 1948 to 1972, were reviewed. Two cases of myeloid leukaemia were found compared with 0-097 expected cases of non-lymphocytic leukaemia (0 05 > P > 0 01). In 5 series of131I treated thyroid carcinomata, 10 cases of myeloid leukaemia occurred in a total of 487 patients, corresponding to a frequency of leukaemia of about 2%. These findings appear to show that131I treatment of thyroid carcinoma is associated with a certain risk of development of leukaemia. This risk must be considered when treatment of localized thyroid carcinoma is planned. © 1973, Cancer Research Campaign. All rights reserved.
CITATION STYLE
Brincker, H., Hansen, H. S., & Andersen, A. P. (1973). Induction of leukaemia by 131I treatment of thyroid carcinoma. British Journal of Cancer, 28(3), 232–237. https://doi.org/10.1038/bjc.1973.142
Mendeley helps you to discover research relevant for your work.